A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT).
Cheng SL, Lin SM, Peng CK, Chan MC, Shen SY, Kuo PH, Lai CH, Lan CC, Chen CY, Lin CH, Liao KM, Feng PH, Wu JT, Wei YF, Xu X, Alfonso-Christancho R, Lai T, Navarro A, Milea D, Perng DW.
Cheng SL, et al. Among authors: navarro a.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666241308406. doi: 10.1177/17534666241308406.
Ther Adv Respir Dis. 2025.
PMID: 39829048